Survival of COVID-19 with Multimorbidity Patients
Background: The outbreak of SARS-CoV-2 abruptly disseminated in early 2020, overcoming the capacity of health systems to respond the pandemic. It was not until the vaccines were launched worldwide that an increase in survival was observed. The objectives of this study were to analyse the characteris...
Guardado en:
Autores principales: | E. Bustos-Vázquez, E. Padilla-González, D. Reyes-Gómez, M. C. Carmona-Ramos, J. A. Monroy-Vargas, A. E. Benítez-Herrera, G. Meléndez-Mier |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0142f979c0ec45bc8cdce947111feb7f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
por: Ravi Kant, et al.
Publicado: (2021) -
An Observational Study on Patients with Acute Limb Ischemia and SARS-CoV-2 Infection: Early and Late Results in Limb Salvage Rate
por: Sorin Barac, et al.
Publicado: (2021) -
COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)
por: Lea Hsu, et al.
Publicado: (2021) -
Can a Nasal/Oral/Ocular Spray Inactivate and Prevent SARS-CoV-2 infection? A hypothesis
por: Fuentes,Edgardo, et al.
Publicado: (2020) -
Changing Features of COVID-19: Characteristics of Infections with the SARS-CoV-2 Delta (B.1.617.2) and Alpha (B.1.1.7) Variants in Southern Italy
por: Daniela Loconsole, et al.
Publicado: (2021)